Cite
MLA Citation
Magnus Jaderberg et al.. “361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A386. http://access.bl.uk/ark:/81055/vdc_100144727621.0x00000a